Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine

Transplant International

Volumn 21, Issue 4, 2008, Pages 397-399

  Domenech, C ^a   Mialou, V ^a   Galambrun, C ^a   Lachaux, A ^b   Mure, P Y ^c   Dijoud, F ^d   Bertrand, Y ^a  

^a Service d'Hémato Immunologie Pédiatrique   (France)

^b HEH   (France)

^c Hop Neurologique N   (France)

^d Hospices Civils de Lyon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BLEEDING; CASE REPORT; COOMBS TEST; DRUG SUBSTITUTION; ERYTHROCYTE TRANSFUSION; HUMAN; LETTER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PARVOVIRUS INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROSING CHOLANGITIS; SPLENECTOMY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; CHILD; CHOLANGITIS, SCLEROSING; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; SYNDROME; TACROLIMUS; TREATMENT OUTCOME;

EID: 40449102536     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00619.x     Document Type: Letter

References (14)

1. Pen CH, Wiliman J, Wang X. Evans syndrome in childhood. J Pediatr 1980 97 : 754.
2. Norton A, Roberts I. Management of Evans Syndrome. Br J Haematol 2005 132 : 125.
3. Jasty R, Strouse PJ, Castle VP. Fatal lymphoproliferative disease as a complication of Evans Syndrome. J Pediatr Haematol Oncol 2000 22 : 460.
4. Prasad M, Chen G, Wang W. Evans syndrome: results of a national survey. J Pediatr Haematol Oncol 1997 19 : 433.
5. Emilia G, Messora C, Longo G, Bertesi M. Long-term salvage treatment by cyclosporine in refractory autoimmune haematological disorders. Br J Haematol 1996 93 : 341.
6. Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A. Treatment of childhood autoimmune haemolytic anemia with Rituximab. Lancet 2001 358 : 1511.
7. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune haemolytic anemia in children. Blood 2003 101 : 3857.
8. Danesi R, Del Tacca M. Hematologic toxicity of immunosuppressive treatment. Transplant Proc 2004 36 : 703.
9. DiGiuseppe JA, Bastacky SI, Shirey RS, Silberman MA, Hutchins GM, Ness PM. Tacrolimus related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. Arch Pathol Lab Med March 1996 120 : 282.
10. Emre S, Genyk Y, Schluger LK, et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int 2000 13 : 73.
11. Abouljoud M, Kumar MS, Brayman KL, Emre S, Bynon JS OLN-452 Study Group. Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant 2002 16 : 168.
12. Bertrand Y, Lefrere JJ, Leverger G, et al. Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet 1985 2 : 382.
13. de la Rubia J, Moscardó F, Arriaga F, Monteagudo E, Carreras C, Marty ML. Acute parvovirus B19 infection as a cause of autoimmune haemolytic anemia. Haematologica 2000 85 : 995.
14. Nobili V, Vento S, Comparcola D, Sartorelli MR, Luciani M, Marcellini M. Autoimmune haemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection. Pediatr Infect Dis J 2004 23 : 184.